Gene · 3980
Papers1,941
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,941
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| X-ray cross-complementing family: the bridge linking DNA damage repair and cancer. | J Transl Med | 2023 | 37679817 | PubTator, text mining | PubMed |
| Polθ is phosphorylated by PLK1 to repair double-strand breaks in mitosis. | Nature | 2023 | 37674080 | PubTator, text mining | PubMed |
| Multi-disciplinary Insights from the First European Forum on Visceral Myopathy 2022 Meeting. | Dig Dis Sci | 2023 | 37650948 | PubTator, text mining | PubMed |
| Mapping the Genetic Interaction Network of PARP inhibitor Response. | bioRxiv | 2023 | 37645833 | PubTator, text mining | PubMed |
| The Role of Poly(ADP-ribose) Polymerase 1 in Nuclear and Mitochondrial Base Excision Repair. | Biomolecules | 2023 | 37627260 | PubTator, text mining | PubMed |
| Understanding DNA Damage Response and DNA Repair in Multiple Myeloma. | Cancers (Basel) | 2023 | 37627183 | PubTator, text mining | PubMed |
| Personalized Medicine in Cancer Pain Management. | J Pers Med | 2023 | 37623452 | PubTator, text mining | PubMed |
| The mechanistic role of cardiac glycosides in DNA damage response and repair signaling. | Cell Mol Life Sci | 2023 | 37584722 | PubTator, text mining | PubMed |
| How ligands regulate the binding of PARP1 with DNA: Deciphering the mechanism at the molecular level. | PLoS One | 2023 | 37582112 | PubTator, text mining | PubMed |
| Simultaneous inhibition of DNA-PK and Polϴ improves integration efficiency and precision of genome editing. | Nat Commun | 2023 | 37580318 | PubTator, text mining | PubMed |
| Generation of Recombinant Nucleosomes Containing Site-Specific DNA Damage. | Methods Mol Biol | 2023 | 37574475 | PubTator, text mining | PubMed |
| CSB Regulates Pathway Choice in Response to DNA Replication Stress Induced by Camptothecin. | Int J Mol Sci | 2023 | 37569794 | PubTator, text mining | PubMed |
| An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective. | Int J Mol Sci | 2023 | 37569269 | PubTator, text mining | PubMed |
| BRCT Domains: Structure, Functions, and Implications in Disease-New Therapeutic Targets for Innovative Drug Discovery against Infections. | Pharmaceutics | 2023 | 37514027 | PubTator, text mining | PubMed |
| LSD1-Based Reversible Inhibitors Virtual Screening and Binding Mechanism Computational Study. | Molecules | 2023 | 37513188 | PubTator, text mining | PubMed |
| Low-Dose Non-Targeted Effects and Mitochondrial Control. | Int J Mol Sci | 2023 | 37511215 | PubTator, text mining | PubMed |
| Single-Nucleotide Polymorphisms in Base-Excision Repair-Related Genes Involved in the Risk of an Occurrence of Non-Alcoholic Fatty Liver Disease. | Int J Mol Sci | 2023 | 37511066 | PubTator, text mining | PubMed |
| Therapeutic Targeting of DNA Replication Stress in Cancer. | Genes (Basel) | 2023 | 37510250 | PubTator, text mining | PubMed |
| Unravelling the Role of PARP1 in Homeostasis and Tumorigenesis: Implications for Anti-Cancer Therapies and Overcoming Resistance. | Cells | 2023 | 37508568 | PubTator, text mining | PubMed |
| Recruitment Kinetics of XRCC1 and RNF8 Following MeV Proton and α-Particle Micro-Irradiation. | Biology (Basel) | 2023 | 37508352 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3980/papers?page=6